SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-067212
Filing Date
2024-05-31
Accepted
2024-05-31 16:29:10
Documents
16
Period of Report
2024-05-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tm2415900d1_8k.htm   iXBRL 8-K 46185
2 EXHIBIT 3.1 tm2415900d1_ex3-1.htm EX-3.1 7381
3 EXHIBIT 3.2 tm2415900d1_ex3-2.htm EX-3.2 17894
4 EXHIBIT 10.1 tm2415900d1_ex10-1.htm EX-10.1 34609
  Complete submission text file 0001104659-24-067212.txt   291686

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA nbse-20240528.xsd EX-101.SCH 3048
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE nbse-20240528_lab.xml EX-101.LAB 34240
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nbse-20240528_pre.xml EX-101.PRE 22381
20 EXTRACTED XBRL INSTANCE DOCUMENT tm2415900d1_8k_htm.xml XML 2863
Mailing Address 350 TECHNOLOGY DRIVE PITTSBURGH PA 15219
Business Address 350 TECHNOLOGY DRIVE PITTSBURGH PA 15219 412-763-3350
NeuBase Therapeutics, Inc. (Filer) CIK: 0001173281 (see all company filings)

IRS No.: 465622433 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35963 | Film No.: 241010186
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)